Brief: Bionik Laboratories Reports Q3 Loss Per Share $0.03
13/02/2018 21:02
Feb 13 (Reuters) - Bionik Laboratories Corp BNKL.PK :
* BIONIK LABORATORIES REPORTS THIRD QUARTER FISCAL YEAR 2018
FINANCIAL RESULTS
* Q3 SALES $261,000
* QTRLY LOSS PER SHARE $0.03
Source text for Eikon: ID:nPn30HGc9a
Further company coverage: BNKL.PK
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Bionik Laboratories
See all newsBrief: Bionik Laboratories Reports A Significant Increase In Patient Volume At Its Acquired Rehabilitation Center In Florida
Brief: Bionik Laboratories Enters Into Distribution Agreement With Pro-Med Technology For The Sale Of Inmotion® Robotic Devices In Hong Kong
Brief: Bionik Laboratories acquires Florida Rehabilitation Center first in strategic national rollout
Brief: Bionik Laboratories Reports Q1 Revenue Of $200,000
Brief: Bionik Laboratories Says Chief Commercial Officer, Terminated Other Than For Cause From Employment, Officer Positions With Co, Units